Crinetics Pharmaceuticals
Stock Forecast, Prediction & Price Target
Crinetics Pharmaceuticals Financial Estimates
Crinetics Pharmaceuticals Revenue Estimates
Crinetics Pharmaceuticals EBITDA Estimates
Crinetics Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.07M N/A | $4.73M 339.42% | $4.01M -15.28% | Avg: $18.01M Low: $2.79M High: $56.39M avg. 349.00% | Avg: $54.01M Low: $10.37M High: $184.72M avg. 199.78% | Avg: $174.19M Low: $33.47M High: $595.72M avg. 222.48% | Avg: $404.45M Low: $77.71M High: $1.38B avg. 132.18% |
Net Income
% change YoY
| $-106.71M N/A | $-159.95M -49.88% | $-214.52M -34.11% | Avg: $-294.30M Low: $-293.83M High: $-188.73M avg. -37.18% | Avg: $-305.29M Low: $-286.87M High: $-142.85M avg. -3.73% | Avg: $-133.27M Low: $-552.51M High: $6.69M avg. 56.34% | Avg: $-4.06M Low: $-16.85M High: $204.06K avg. 96.94% |
EBITDA
% change YoY
| $-107.70M N/A | $-167.88M -55.87% | $-221.51M -31.94% | Avg: $-18.01M Low: $-56.39M High: $-2.79M avg. 91.86% | Avg: $-54.01M Low: $-184.72M High: $-10.37M avg. -199.78% | Avg: $-174.19M Low: $-595.72M High: $-33.47M avg. -222.48% | Avg: $-404.45M Low: $-1.38B High: $-77.71M avg. -132.18% |
EPS
% change YoY
| -$2.78 N/A | -$3.08 -10.79% | -$3.69 -19.80% | Avg: -$3.86 Low: -$5.06 High: -$3.25 avg. -4.48% | Avg: -$3.81 Low: -$4.94 High: -$2.46 avg. 1.21% | Avg: -$2.3 Low: -$9.51 High: $0.12 avg. 39.74% | Avg: -$0.07 Low: -$0.29 High: $0 avg. 96.94% |
Operating Expenses
% change YoY
| $108.78M N/A | $172.61M 58.68% | $226.62M 31.28% | Avg: $1.12B Low: $174.07M High: $3.51B avg. 395.17% | Avg: $3.36B Low: $646.43M High: $11.50B avg. 199.78% | Avg: $10.84B Low: $2.08B High: $37.10B avg. 222.48% | Avg: $25.18B Low: $4.84B High: $86.14B avg. 132.18% |
FAQ
What is Crinetics Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 28.09% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is -293.83M, average is -294.30M and high is -188.73M.
What is Crinetics Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 225.86% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $2.79M, average is $18.01M and high is $56.39M.
What is Crinetics Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 33.35% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is -$5.06, average is -$3.86 and high is $-3.25.
What is the best performing analyst?
In the last twelve months analysts have been covering Crinetics Pharmaceuticals stock. The most successful analyst is Leland Gershell.